InvestorsHub Logo

JUST 10-11-12

04/25/21 6:37 PM

#356838 RE: taas #356833

But people always have a choice and more Pfizer will be available later in the year. At this stage we will not be making Pfizer available to those 50 and over."
"(For over 50s) we recommend AstraZeneca, the risk-benefit for over 50 is vastly in favour of being vaccinated."
Professor Murphy said the vaccine rollout was going well and aged care residents were "almost done".

seems to be a way of making sure everyone is vaccinated.


—from news channel in Australia.